Current Pathological and Laboratory Considerations in the Diagnosis of Disseminated Intravascular Coagulation
- PMID: 27578502
- PMCID: PMC5011102
- DOI: 10.3343/alm.2016.36.6.505
Current Pathological and Laboratory Considerations in the Diagnosis of Disseminated Intravascular Coagulation
Erratum in
-
Erratum: Current Pathological and Laboratory Considerations in the Diagnosis of Disseminated Intravascular Coagulation.Ann Lab Med. 2017 Jan;37(1):95. doi: 10.3343/alm.2017.37.1.95. Ann Lab Med. 2017. PMID: 27834077 Free PMC article.
Abstract
Systemically sustained thrombin generation in vivo is the hallmark of disseminated intravascular coagulation (DIC). Typically, this is in response to a progressing disease state that is associated with significant cellular injury. The etiology could be infectious or noninfectious, with the main pathophysiological mechanisms involving cross-activation among coagulation, innate immunity, and inflammatory responses. This leads to consumption of both pro- and anticoagulant factors as well as endothelial dysfunction and disrupted homeostasis at the blood vessel wall interface. In addition to the release of tissue plasminogen activator (tPA) and soluble thrombomodulin (sTM) following cellular activation and damage, respectively, there is the release of damage-associated molecular patterns (DAMPs) such as extracellular histones and cell-free DNA. Extracellular histones are increasingly recognized as significantly pathogenic in critical illnesses through direct cell toxicity, the promotion of thrombin generation, and the induction of neutrophil extracellular trap (NET) formation. Clinically, high circulating levels of histones and histone-DNA complexes are associated with multiorgan failure, DIC, and adverse patient outcomes. Their measurements as well as that of other DAMPs and molecular markers of thrombin generation are not yet applicable in the routine diagnostic laboratory. To provide a practical diagnostic tool for acute DIC, a composite scoring system using rapidly available coagulation tests is recommended by the International Society on Thrombosis and Haemostasis. Its usefulness and limitations are discussed alongside the advances and unanswered questions in DIC pathogenesis.
Keywords: Damage-associated molecular patterns; Disseminated intravascular coagulation; Molecular markers.
Conflict of interest statement
Authors' Disclosures of Potential Conflicts of Interest: No potential conflicts of interest relevant to this article were reported.
Figures


Similar articles
-
[A novel molecular marker for thrombus formation and life prognosis--clinical usefulness of measurement of soluble fibrin monomer-fibrinogen complex (SF)].Rinsho Byori. 2004 Apr;52(4):355-61. Rinsho Byori. 2004. PMID: 15164605 Review. Japanese.
-
Circulating levels of DNA-histone complex and dsDNA are independent prognostic factors of disseminated intravascular coagulation.Thromb Res. 2015 Jun;135(6):1064-9. doi: 10.1016/j.thromres.2015.03.014. Epub 2015 Mar 14. Thromb Res. 2015. PMID: 25843168
-
Trauma-induced innate immune activation and disseminated intravascular coagulation.J Thromb Haemost. 2024 Feb;22(2):337-351. doi: 10.1016/j.jtha.2023.09.028. Epub 2023 Oct 8. J Thromb Haemost. 2024. PMID: 37816463 Review.
-
[Effect of thrombelastography in the diagnosis of disseminated intravascular coagulation in children].Zhonghua Er Ke Za Zhi. 2014 Feb;52(2):128-32. Zhonghua Er Ke Za Zhi. 2014. PMID: 24739725 Chinese.
-
An audit of disseminated intravascular coagulation screen requests at an academic hospital laboratory in central South Africa.Int J Lab Hematol. 2021 Oct;43(5):1174-1180. doi: 10.1111/ijlh.13461. Epub 2021 Feb 1. Int J Lab Hematol. 2021. PMID: 33522121
Cited by
-
Machine learning-based diagnosis for disseminated intravascular coagulation (DIC): Development, external validation, and comparison to scoring systems.PLoS One. 2018 May 2;13(5):e0195861. doi: 10.1371/journal.pone.0195861. eCollection 2018. PLoS One. 2018. PMID: 29718941 Free PMC article.
-
Disseminated Intravascular Coagulopathy in Cranial Surgery: Case Report and Review of the Literature.Case Rep Oncol. 2022 Jun 17;15(2):624-629. doi: 10.1159/000523897. eCollection 2022 May-Aug. Case Rep Oncol. 2022. PMID: 35949902 Free PMC article.
-
The mechanism by which enoxaparin sodium-high-viscosity bone cement reduces thrombosis by regulating CD40 expression in endothelial cells.BMC Musculoskelet Disord. 2022 May 30;23(1):513. doi: 10.1186/s12891-022-05469-5. BMC Musculoskelet Disord. 2022. PMID: 35637498 Free PMC article.
-
Application of the International Society on Thrombosis and Haemostasis Scoring System in Evaluation of Disseminated Intravascular Coagulation in Patients with Acute Leukemias.South Asian J Cancer. 2021 Nov 24;10(4):241-245. doi: 10.1055/s-0041-1733347. eCollection 2021 Dec. South Asian J Cancer. 2021. PMID: 34984203 Free PMC article.
-
Argatroban Treatment and Decreased Fibrinogen in a Septic Patient.Cureus. 2020 Apr 7;12(4):e7573. doi: 10.7759/cureus.7573. Cureus. 2020. PMID: 32391222 Free PMC article.
References
-
- Crawley JT, Zanardelli S, Chion CK, Lane DA. The central role of thrombin in hemostasis. J Thromb Haemost. 2007;5(S1):95–101. - PubMed
-
- Taylor FB, Jr, Wada H, Kinasewitz G. Description of compensated and uncompensated disseminated intravascular coagulation (DIC) responses (non-overt and overt DIC) in baboon models of intravenous and intraperitoneal Escherichia coli sepsis and in the human model of endotoxemia: toward a better definition of DIC. Crit Care Med. 2000;28(9S):S12–S19. - PubMed
-
- Taylor FB, Jr, Toh CH, Hoots WK, Wada H, Levi M Scientific Subcommittee on Disseminated Intravascular Coagulation of the International Society on Thrombosis and Haemostasis. Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation. Thromb Haemost. 2001;86:1327–1330. - PubMed
-
- Bakhtiari K, Meijers JC, de Jonge E, Levi M. Prospective validation of the International Society of Thrombosis and Haemostasis scoring system for disseminated intravascular coagulation. Crit Care Med. 2004;32:2416–2421. - PubMed
-
- Kjalke M, Monroe DM, Hoffman M, Oliver JA, Ezban M, Roberts HR. Active site-inactivated factors VIIa, Xa, and IXa inhibit individual steps in a cell-based model of tissue factor-initiated coagulation. Thromb Haemost. 1998;80:578–584. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources